Australia’s Medicinal-Cannabis Sales Have Posted Their First Sharp Reversal
A new analysis of Australian Health Department data says medicinal-cannabis units sold fell 28.5 percent in the second half of 2025, suggesting tougher scrutiny of prescribing, supply and advertising is already cutting into one of the world’s fastest-growing medical markets.
Australia’s medicinal-cannabis market has printed its first clear reverse. Penington Institute said in an April 2026 analysis that units sold fell to 2.65 million in the second half of 2025, down from 3.70 million in the first half. That is a 28.5 percent decline in six months.
Read article